Form4insider filings, from the source

SEC Form 4 · accession 0000904454-17-000469

Clovis Oncology, Inc. · CLVS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jun 23, 2017
Accepted (ET)
Jun 27, 2017 · 4:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jun 23, 2017J286,857—D1,000,000IBy Domain Partners VII, L.P.
Common StockF1,F2Jun 23, 2017J2,869—A92,518IBy One Palmer Square Associates VII, LLC
Common StockF2holding———35,506IBy DP VII Associates, L.P.
Common StockF2holding———32,760IBy Domain Associates, LLC
Common Stockholding———2,185D
Common StockF3holding———2,927IBy Susan W. and James C. Blair Family L.P.

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses